PCM Inc:企業の戦略・SWOT・財務情報

◆英語タイトル:PCM Inc - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C2260
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:技術・通信
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

PCM Inc – Strategy, SWOT and Corporate Finance Report
Summary

PCM Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

PCM, Inc. (PCM) is a provider of technology products, software and solutions. It primarily sells device products, servers, storage products, networks, printers, and related accessories and devices through direct sales force and ecommerce channels. It offers its service to businesses, state, local and federal government and educational institutions. The company also provides software asset management, and hardware sales and services, as well as software value-added reseller services, managed services, cloud-based services, security, data center, networking, consulting, and information technology (IT) management and related services. It is headquartered in El Segundo, California, the US.

Scope

- Detailed information on PCM Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting PCM Inc in the form of a SWOT analysis
- An in-depth view of the business model of PCM Inc including a breakdown and examination of key business segments
- Intelligence on PCM Inc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about PCM Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of PCM Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess PCM Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on PCM Inc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
PCM Inc: Company Overview 9
PCM Inc: Overview and Key Facts 9
PCM Inc: Overview 9
PCM Inc: Key Facts 9
PCM Inc: Key Employees 11
PCM Inc: Key Employee Biographies 12
PCM Inc: Major Products and Services 15
PCM Inc: Company History 19
PCM Inc: Management Statement 22
PCM Inc: Locations and Subsidiaries 25
PCM Inc: Key Competitors 26
PCM Inc: Company Analysis 27
PCM Inc: Business Description 27
PCM Inc: SWOT Analysis 28
PCM Inc: SWOT Overview 28
PCM Inc: Strengths 28
PCM Inc: Weaknesses 29
PCM Inc: Opportunities 29
PCM Inc: Threats 31
PCM Inc: Corporate Financial Deals Activity 32
PCM Inc: Financial Deals Overview 32
PCM Inc: Targets and Partners 34
PCM Inc: Top Deals 2014 – 2018YTD* 35
PCM Inc: Advisors 36
PCM Inc: Top Legal Advisors 36
PCM Inc: Mergers and Acquisitions 37
PCM Inc: Recent Developments 38
PCM Inc: News and Events Summary 38
PCM Inc: Business Expansion 39
PCM Inc: Contracts 40
PCM Inc: Corporate Governance 40
PCM Inc: Financial Performance 40
PCM Inc: Red Flags/DistressSignals 42
PCM Inc: Strategy and Operations 43
Appendix 44
Contact Us 44
Methodology 44
About MarketLine 45

List of Tables
Table 1: PCM Inc: Key Facts
Table 2: PCM Inc: Key Employees
Table 3: PCM Inc: Locations and Subsidiaries
Table 4: PCM Inc: Key Competitors
Table 5: PCM Inc: Deal Activity by Deal Type - Volume (TTM*)
Table 6: PCM Inc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: PCM Inc: M&A Average Deal Size - Value (US$m)
Table 8: PCM Inc: Targets and Partners
Table 9: PCM Inc: Top Deals 2014 - 2018YTD*
Table 10: PCM Inc: Legal Advisor Ranking by Value (US$m)
Table 11: PCM Inc: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: PCM Inc: M&A Activity by Geography (2014 - YTD*2018)
Table 13: PCM Inc: News and Events Summary
Table 14: PCM Inc: Business Expansion
Table 15: PCM Inc: Contracts
Table 16: PCM Inc: Corporate Governance
Table 17: PCM Inc: Financial Performance
Table 18: PCM Inc: Red Flags/DistressSignals
Table 19: PCM Inc: Strategy and Operations

List of Figures
Figure 1: PCM Inc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: PCM Inc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: PCM Inc: M&A Average Deal Size - Value (US$m)
Figure 4: PCM Inc: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: PCM Inc: M&A Activity by Geography (2014 - YTD*2018)

★海外企業調査レポート[PCM Inc:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Polenergia SA (PEP):企業の財務・戦略的SWOT分析
    Polenergia SA (PEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Verge Genomics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Verge Genomics Inc (Verge Genomics) is a drug discovery company that focuses on the discovery of treatments for neurodegenerative diseases using human genomic data and machine learning. The company combines large-scale molecular, genomic and genetic data on multiple platforms and technologie …
  • Immupharma Plc (IMM):製薬・医療:M&Aディール及び事業提携情報
    Summary ImmuPharma Plc (ImmuPharma) develops novel drugs for the treatment of serious medical conditions with unmet medical need. ImmuPharma develops drugs for the treatment of lupus, cancer, moderate to severe pain, highly resistant hospital-acquired infections such as methicillin-resistant staphyl …
  • Fortum Corporation (FUM1V)-エネルギー分野:企業M&A・提携分析
    Summary Fortum Corporation (Fortum) is a clean energy company, which generates, distributes and sells heat and electricity. The company undertakes operation and maintenance of power plants; and offers energy-related services. Fortum's operational assets include hydropower plants, condensing power pl …
  • Dominion Energy Inc:企業の発電所・SWOT分析2018
    Dominion Energy Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Mount Tam Biotechnologies Inc (MNTM)-製薬・医療分野:企業M&A・提携分析
    Summary Mount Tam Biotechnologies Inc (Mount Tam Biotechnologies), a subsidiary of TabacaleraYsidron Inc is a provider of pharmaceutical products that focuses on the development and commercialization of medical compounds for autoimmune diseases. The company’s lead product candidate TAM-0, a rapamyci …
  • Eone Diagnomics Genome Center Co Ltd (245620):企業の製品パイプライン分析
    Summary Eone Diagnomics Genome Center Co Ltd (EDGC) develops genome analysis technology solutions. The company focuses on the development of clinical genomic products for non-invasive prenatal test; newborn genetic screening test, hereditary cancer prediction test, female cancer prediction test and …
  • FCA US LLC:企業の戦略的SWOT分析
    FCA US LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Sime Darby Berhad:企業の戦略・SWOT・財務分析
    Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report Summary Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Ardelyx Inc (ARDX):企業の財務・戦略的SWOT分析
    Summary Ardelyx Inc (Ardelyx) is a developer of small molecule therapeutics for treatment of cardio-renal, gastrointestinal and metabolic disorders. The company provides product portfolio such as tenapanor, RDX227675, RDX98940 and RDX013, among others. Its products are used for hyperphosphatemia in …
  • Prismic Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Prismic Pharmaceuticals Inc (Prismic Pharmaceuticals) is a specialty pharmaceutical company that offers development of prescription drugs. The company offers research and development programs for prescription product candidates and provides unique safety profiles. It develops drugs for infla …
  • Bankinter Banca Privada:企業の戦略・SWOT・財務分析
    Bankinter Banca Privada - Strategy, SWOT and Corporate Finance Report Summary Bankinter Banca Privada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Aslan Pharmaceuticals Pte Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Aslan Pharmaceuticals Pte Ltd (Aslan), a subsidiary of Aslan Pharmaceuticals Ltd is a biotechnology company that offers immuno-oncology agents and targeted therapies. The company’s pipeline products comprise varlitinib, ASLAN002, ASLAN003 and ASLAN004. Its ASLAN002 is a small molecule inhibi …
  • Komunalna poistovna, a.s. Vienna Insurance Group:企業の戦略的SWOT分析
    Komunalna poistovna, a.s. Vienna Insurance Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • Sanofi-aventis Canada Inc-製薬・医療分野:企業M&A・提携分析
    Summary Sanofi-Aventis Canada Inc (Sanofi- Aventis), a subsidiary of Sanofi is a healthcare products provider that discovers, develops, and distributes therapeutic solutions. The company offers skin and hair care, cosmeceuticals, pain relief, health and wellness products. Its skin and hair care prod …
  • Partners HealthCare System Inc:企業の戦略的SWOT分析
    Partners HealthCare System Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Qisda Corporation:企業の戦略・SWOT・財務分析
    Qisda Corporation - Strategy, SWOT and Corporate Finance Report Summary Qisda Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • EyePoint Pharmaceuticals Inc (PSDV):医療機器:M&Aディール及び事業提携情報
    Summary EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. Its durasert …
  • Leclanche SA (LECN):電力:M&Aディール及び事業提携情報
    Summary Leclanche SA (Leclanche) is a custom battery storage solutions provider. The company develops and manufactures energy storage systems with large format lithium-ion cells. It also offers batteries and storage systems including portable energy systems, accumulators, torches and chargers. The c …
  • ImCheck Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary ImCheck Therapeutics SAS (ImCheck Therapeutics) is an independent biotechnology company that develops drugs for cancer and auto-immune disorders. The company is developing two first-in-class immunomodulator antibodies that are effective against adaptive and innate immunity to treat cancer an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆